Finding 1094590 (2023-014)

Material Weakness Repeat Finding
Requirement
H
Questioned Costs
-
Year
2023
Accepted
2025-01-08

AI Summary

  • Core Issue: The Organization lacks consistent controls over the period of performance requirement, risking grant expenditures outside the allowed timeframe.
  • Impacted Requirements: This finding relates to compliance with 2 CFR sections on budget periods, financial obligations, and closeout procedures.
  • Recommended Follow-Up: Management should enhance controls to ensure all expenses align with procurement policies and meet the period of performance requirements.

Finding Text

2023-014 Period of Performance Assistance Listing No.: 14.267 Continuum of Care Program Condition: The Organization was unable to demonstrate consistent controls over the period of performance requirement. Criteria: The requirements for the period of performance are contained in 2 CFR section 200.1 Definitions for “budget period,” “financial obligations,” “period of performance,” 2 CFR section 200.308 (revision of budget and program plans), 2 CFR section 200.309 (modifications to period of performance), 2 CFR section 200.344 (closeout), program legislation, federal awarding agency regulations; and the terms and conditions of the award. Questioned Costs There are no questioned costs. Cause: The Organization did not have good controls on ensuring the period of performance requirement was met due to staff turn over. Effect: The Organization could have grant expenditures outside the grant period. Perspective: Thirty-one of forty items selected for testing did not have documentation of the control over compliance with the period of performance requirement. Repeat Finding: This is a repeat finding. See finding 2022-017. Recommendation: In order to prevent future occurences of this deficiency, we recommend that management expand controls to ensure that they are able to demonstrate that all expenses meet their procurement policy. Auditee's Response: The Organization agrees with the finding. See attached corrective action plan.

Categories

Procurement, Suspension & Debarment Period of Performance

Other Findings in this Audit

  • 518138 2023-012
    Material Weakness Repeat
  • 518139 2023-012
    Material Weakness Repeat
  • 518140 2023-012
    Material Weakness Repeat
  • 518141 2023-012
    Material Weakness Repeat
  • 518142 2023-012
    Material Weakness Repeat
  • 518143 2023-013
    Material Weakness Repeat
  • 518144 2023-013
    Material Weakness Repeat
  • 518145 2023-013
    Material Weakness Repeat
  • 518146 2023-014
    Material Weakness Repeat
  • 518147 2023-014
    Material Weakness Repeat
  • 518148 2023-014
    Material Weakness Repeat
  • 518149 2023-015
    Material Weakness Repeat
  • 518150 2023-015
    Material Weakness Repeat
  • 518151 2023-015
    Material Weakness Repeat
  • 518152 2023-016
    Material Weakness
  • 518153 2023-016
    Material Weakness
  • 1094580 2023-012
    Material Weakness Repeat
  • 1094581 2023-012
    Material Weakness Repeat
  • 1094582 2023-012
    Material Weakness Repeat
  • 1094583 2023-012
    Material Weakness Repeat
  • 1094584 2023-012
    Material Weakness Repeat
  • 1094585 2023-013
    Material Weakness Repeat
  • 1094586 2023-013
    Material Weakness Repeat
  • 1094587 2023-013
    Material Weakness Repeat
  • 1094588 2023-014
    Material Weakness Repeat
  • 1094589 2023-014
    Material Weakness Repeat
  • 1094591 2023-015
    Material Weakness Repeat
  • 1094592 2023-015
    Material Weakness Repeat
  • 1094593 2023-015
    Material Weakness Repeat
  • 1094594 2023-016
    Material Weakness
  • 1094595 2023-016
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
16.575 Crime Victim Compensation $240,723
93.788 Opioid Str $167,964
93.558 Temporary Assistance for Needy Families $83,666
14.267 Continuum of Care Program $60,880
94.006 Americorps $46,346
16.588 Violence Against Women Formula Grants $15,921
10.558 Child and Adult Care Food Program $9,431